Liping Cao
7PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 15, 2025
Targeted delivery of the PKMYT1 inhibitor RP-6306 mediates PANoptosis in pancreatic cancer via mitotic catastrophe.Jingyun Chen, Jianghao Ren, Chaolei Zhang
|Aug 02, 2024
Fisetin disrupts mitochondrial homeostasis via superoxide dismutase 2 acetylation in pancreatic adenocarcinoma.Yimin Ding, Dafei Xie, Chengjie Xu
|Jan 25, 2024
Whether Detection of Gene Mutations Could Identify Low- or High-Risk Papillary Thyroid Microcarcinoma? Data from 393 Cases Using the Next-Generation Sequencing.Lei Jin, Liang Zhou, Jian-Biao Wang
|Nov 17, 2022
Scaffold-based three-dimensional cell model of pancreatic cancer is more suitable than scaffold-free three-dimensional cell model of pancreatic cancer for drug discovery.Dafei Xie, Shengnan Jia, Dongnan Ping
|Jun 06, 2022
A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.Yifeng Jin, Xiaofan Pu, Dongnan Ping
|Oct 23, 2020
Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.Guoping Ding, Xiaodong Xu, Dan Li
Pageof 2
